Cannabics Pharmaceuticals Appoints Estery Giloz-Ran and Eran Ballan Directors

6/25/19

Dr. Estery Giloz-Ran

Cannabics Pharmaceuticals Inc.,a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced their appointment of two new directors, Dr. Estery Giloz-Ran and Eran Ballan, Esq.

Dr. Giloz-Ran, has a long record of leveraging strategic planning and problem solving to drive business growth. She is a Certified Public Accountant and holds a PhD in tax, accounting and finance from Ben- Gurion University in Israel.

Eran Ballan, Esq., brings exceptional management experience at large and complex corporate entitiesin international markets. Mr. Ballan served as Partner, and Head of the biotech department at Naschitz Brandes Amir, one of the largest law firms in Israel.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.

Connect with these Baltimore Professionals on LinkedIn

  • Edwin Warfield

    Editor in Chief, Warfield Digital

    Connect
  • Jean Halle

    Independent Consultant

    Connect
  • Larry Lichtenauer

    President of Lawrence Howard & Associates

    Connect
  • Newt Fowler

    Partner at Womble Carlyle, LLP

    Connect
  • David Crowley

    Owner at Develop DC

    Connect
  • Carolyn Stinson

    Stinson Marketing Group

    Connect